Detalhe da pesquisa
1.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38569872
2.
Real-world persistence of multiple sclerosis disease-modifying therapies.
Eur J Neurol
; 31(7): e16289, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38567516
3.
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J Neurol Neurosurg Psychiatry
; 94(12): 1004-1011, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37414534
4.
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Mult Scler
; 26(1): 79-90, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31397221
5.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Mult Scler
; 23(2): 266-276, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27055805
6.
Defining secondary progressive multiple sclerosis.
Brain
; 139(Pt 9): 2395-405, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27401521
7.
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 87(12): 1343-1349, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27810919
8.
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
Mult Scler
; 22(4): 520-32, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26199347
9.
Defining reliable disability outcomes in multiple sclerosis.
Brain
; 138(Pt 11): 3287-98, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26359291
10.
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.
Ann Neurol
; 76(6): 880-90, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25283272
11.
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Mult Scler
; 21(9): 1159-71, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25480857
12.
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Mult Scler
; 20(6): 739-46, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24107309
13.
Risk of relapse phenotype recurrence in multiple sclerosis.
Mult Scler
; 20(11): 1511-22, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24777276
14.
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Brain
; 136(Pt 12): 3609-17, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24142147
15.
Big Multiple Sclerosis Data network: an international registry research network.
J Neurol
; 271(6): 3616-3624, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38561543
16.
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase.
Mult Scler J Exp Transl Clin
; 10(2): 20552173241247182, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38800132
17.
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
J Neurol
; 271(1): 472-485, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37768389
18.
A Neurology Advanced Referral Management System (NARMS) Reduces Face-to-Face Consultations By Over Sixty Percent.
Ulster Med J
; 92(1): 19-23, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36762140
19.
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis.
JAMA Neurol
; 80(8): 789-797, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37307006
20.
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.
J Neurol Neurosurg Psychiatry
; 83(3): 305-10, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22205675